Our findings underscore the role of oxidative stress-inflammation crosstalk in ARHL, suggesting therapeutic targets for preventing presbycusis in aging populations.
Pisani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: